Skip to main navigation Skip to search Skip to main content

Implications of law's response to mitochondrial donation

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Changes to Australian law in 2022 made Australia the second country to expressly permit the clinical use of mitochondrial donation (MD), a technology that makes heritable changes to the human genome. This paper considers these changes in the context of Australia’s broader controls on human embryo use to provide insights into future regulatory responses to other emerging genetic technologies, which could be used in reproduction.

Original languageEnglish
Article number20
Number of pages15
JournalLaws
Volume13
Issue number2
DOIs
Publication statusPublished - Apr 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • legal regulation
  • mitochondrial donation
  • genome editing
  • genetic technology
  • embryo research

Cite this